EPIX Pharmaceuticals, Inc. (EPIX) has seen shares essentially chopped in half today. Early this morning the company announced that it was discontinuing its PRX-00023 clinical development program after Phase IIb trials over a lack…
Amicus Therapeutics (NASDAQ: FOLD) had a late afternoon surge, up 7% to $10.73. The 52 week range is $9.00 to $18.22. Baxter International (NYSE: BAX)—contaminant in recalled Heparin identified by the FDA today. Shares…
CardioNet Inc. (NASDAQ: BEAT) priced its 4.5 million share IPO at a price of $18.00 per share. The San Diego, California-based provider of real-time patient heart monitoring systems had originally set the range at…
Pharmacopeia (Nasdaq: PCOP) has announced that it will receive a milestone payment of $5 million from GlaxoSmithKline (NYSE: GSK), bringing the total received to over $16 million in connection with its ongoing development and…
Biotech’s are sliding along with all the others today. A look at the highlights and outliers: Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that arthritis and psoriasis drug Enbrel will now have a…
Cardiome Pharma (NASDAQ: CRME) picked a bad day for good news. According to the AP the company announced "interim midstage data showed its experimental drug vernakalant was safe and effective in treating abnormal heart…
Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a company where its is a better fit. According to the FT, that includes Pepsi…
In an SEC Filing, it was disclosed that Carl Icahn has taken a larger stake as an activist in Enzon Pharmaceuticals Inc. (NASDAQ: ENZN). The stake is listed as 6.93% for just over 3.07…
Xcorporeal, Inc. (AMEX: XCR) is a potential undiscovered gem in microcap and low-priced stock investing, and it is in the arena of kidney dialysis. This week’s "INSIDE WALL STREET" segment in Business Week featured…
Transition Therapeutics Inc. (NASDAQ: TTHI) is seeing shares surge in after-hours activity. It has signed a pact with Eli Lilly and Co. (NYSE: ELY) where Lilly will acquire exclusive rights to its Gastrin-based therapies…
Salient Surgical Technologies, Inc. has filed to come public via an initial public offering and has applied to trade on the NASDAQ under the ticker "SLNT." The company lists that it will sell up…
CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up to $50 million in securities sales. It has applied to have the common stock…
Medco Health Solutions, Inc. (NYSE: MHS) has just made an SEC Filing that will allow the company to raise capital in the near future if it chooses. While this could be a large offering,…
First we saw an earnings warning out of WellPoint (NYSE: WLP) which hurt that stock and most shares in the health insurance field yesterday. WellPoint cited several factors, including medical costs, lower fully insured…
WellPoint (NYSE: WLP) lowered guidance last night and put 2008 EPS targets at a new range of $5.76 to $6.01 EPS from an original $6.41 estimates. It also put revenues at $62 Billion, yet…